Logo image of DEA

EASTERLY GOVERNMENT PROPERTI (DEA) Stock Fundamental Analysis

NYSE:DEA - New York Stock Exchange, Inc. - US27616P1030 - REIT - Currency: USD

10.79  +0.1 (+0.94%)

After market: 10.82 +0.03 (+0.28%)

Fundamental Rating

4

Overall DEA gets a fundamental rating of 4 out of 10. We evaluated DEA against 129 industry peers in the Diversified REITs industry. There are concerns on the financial health of DEA while its profitability can be described as average. While showing a medium growth rate, DEA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year DEA was profitable.
In the past year DEA had a positive cash flow from operations.
DEA had positive earnings in each of the past 5 years.
Each year in the past 5 years DEA had a positive operating cash flow.
DEA Yearly Net Income VS EBIT VS OCF VS FCFDEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

1.2 Ratios

With a Return On Assets value of 0.58%, DEA perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
DEA has a Return On Equity (1.37%) which is in line with its industry peers.
DEA's Return On Invested Capital of 1.97% is on the low side compared to the rest of the industry. DEA is outperformed by 70.63% of its industry peers.
DEA had an Average Return On Invested Capital over the past 3 years of 2.01%. This is in line with the industry average of 3.11%.
Industry RankSector Rank
ROA 0.58%
ROE 1.37%
ROIC 1.97%
ROA(3y)0.92%
ROA(5y)0.71%
ROE(3y)2.06%
ROE(5y)1.57%
ROIC(3y)2.01%
ROIC(5y)1.84%
DEA Yearly ROA, ROE, ROICDEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 0.5 1 1.5 2

1.3 Margins

Looking at the Profit Margin, with a value of 6.06%, DEA is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Profit Margin of DEA has grown nicely.
The Operating Margin of DEA (25.11%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DEA has grown nicely.
Looking at the Gross Margin, with a value of 66.01%, DEA is in line with its industry, outperforming 42.06% of the companies in the same industry.
In the last couple of years the Gross Margin of DEA has declined.
Industry RankSector Rank
OM 25.11%
PM (TTM) 6.06%
GM 66.01%
OM growth 3Y0.93%
OM growth 5Y3.54%
PM growth 3Y9.91%
PM growth 5Y17.22%
GM growth 3Y-2.38%
GM growth 5Y-1.67%
DEA Yearly Profit, Operating, Gross MarginsDEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DEA is destroying value.
DEA has more shares outstanding than it did 1 year ago.
DEA has more shares outstanding than it did 5 years ago.
DEA has a worse debt/assets ratio than last year.
DEA Yearly Shares OutstandingDEA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
DEA Yearly Total Debt VS Total AssetsDEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

DEA has an Altman-Z score of 0.32. This is a bad value and indicates that DEA is not financially healthy and even has some risk of bankruptcy.
DEA's Altman-Z score of 0.32 is on the low side compared to the rest of the industry. DEA is outperformed by 65.08% of its industry peers.
DEA has a debt to FCF ratio of 46.93. This is a negative value and a sign of low solvency as DEA would need 46.93 years to pay back of all of its debts.
The Debt to FCF ratio of DEA (46.93) is comparable to the rest of the industry.
DEA has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.12, DEA perfoms like the industry average, outperforming 51.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 46.93
Altman-Z 0.32
ROIC/WACC0.3
WACC6.46%
DEA Yearly LT Debt VS Equity VS FCFDEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

DEA has a Current Ratio of 1.23. This is a normal value and indicates that DEA is financially healthy and should not expect problems in meeting its short term obligations.
DEA has a Current ratio of 1.23. This is comparable to the rest of the industry: DEA outperforms 53.97% of its industry peers.
DEA has a Quick Ratio of 1.23. This is a normal value and indicates that DEA is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.23, DEA perfoms like the industry average, outperforming 56.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
DEA Yearly Current Assets VS Current LiabilitesDEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The earnings per share for DEA have decreased strongly by -45.45% in the last year.
DEA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.55% yearly.
Looking at the last year, DEA shows a small growth in Revenue. The Revenue has grown by 2.89% in the last year.
DEA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-45.45%
EPS 3Y8.2%
EPS 5Y11.55%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)2.89%
Revenue growth 3Y5.43%
Revenue growth 5Y12.33%
Sales Q2Q%3.84%

3.2 Future

Based on estimates for the next years, DEA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.51% on average per year.
The Revenue is expected to grow by 6.98% on average over the next years.
EPS Next Y16.95%
EPS Next 2Y12.95%
EPS Next 3Y27.51%
EPS Next 5YN/A
Revenue Next Year4.47%
Revenue Next 2Y6.67%
Revenue Next 3Y7.48%
Revenue Next 5Y6.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DEA Yearly Revenue VS EstimatesDEA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DEA Yearly EPS VS EstimatesDEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 59.94 indicates a quite expensive valuation of DEA.
DEA's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. DEA is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 44.51, which means the current valuation is very expensive for DEA.
Based on the Price/Forward Earnings ratio, DEA is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, DEA is valued quite expensively.
Industry RankSector Rank
PE 59.94
Fwd PE 44.51
DEA Price Earnings VS Forward Price EarningsDEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

DEA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, DEA is valued a bit cheaper than the industry average as 60.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 36.29
EV/EBITDA 15.18
DEA Per share dataDEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DEA's earnings are expected to grow with 27.51% in the coming years.
PEG (NY)3.54
PEG (5Y)5.19
EPS Next 2Y12.95%
EPS Next 3Y27.51%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.90%, DEA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 18.48, DEA pays a better dividend. On top of this DEA pays more dividend than 88.10% of the companies listed in the same industry.
DEA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 9.9%

5.2 History

The dividend of DEA decreases each year by -1.28%.
DEA has been paying a dividend for at least 10 years, so it has a reliable track record.
DEA has decreased its dividend recently.
Dividend Growth(5Y)-1.28%
Div Incr Years0
Div Non Decr Years1
DEA Yearly Dividends per shareDEA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

DEA pays out 640.24% of its income as dividend. This is not a sustainable payout ratio.
DP640.24%
EPS Next 2Y12.95%
EPS Next 3Y27.51%
DEA Yearly Income VS Free CF VS DividendDEA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M
DEA Dividend Payout.DEA Dividend Payout, showing the Payout Ratio.DEA Dividend Payout.PayoutRetained Earnings

EASTERLY GOVERNMENT PROPERTI

NYSE:DEA (2/21/2025, 8:13:34 PM)

After market: 10.82 +0.03 (+0.28%)

10.79

+0.1 (+0.94%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-25 2025-02-25/amc
Inst Owners78.58%
Inst Owner Change4.92%
Ins Owners6.54%
Ins Owner Change0.1%
Market Cap1.14B
Analysts50.77
Price Target12.85 (19.09%)
Short Float %5.22%
Short Ratio3.85
Dividend
Industry RankSector Rank
Dividend Yield 9.9%
Yearly Dividend1.17
Dividend Growth(5Y)-1.28%
DP640.24%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.89%
Min EPS beat(2)-20.79%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-17.71%
Min EPS beat(4)-39.07%
Max EPS beat(4)-0.99%
EPS beat(8)2
Avg EPS beat(8)24.14%
EPS beat(12)2
Avg EPS beat(12)4.01%
EPS beat(16)3
Avg EPS beat(16)-0.98%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-3.47%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-2.19%
Min Revenue beat(4)-3.47%
Max Revenue beat(4)-0.15%
Revenue beat(8)2
Avg Revenue beat(8)-1.05%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)4
Avg Revenue beat(16)-1.36%
PT rev (1m)-4.3%
PT rev (3m)-7.81%
EPS NQ rev (1m)28.57%
EPS NQ rev (3m)50%
EPS NY rev (1m)7.32%
EPS NY rev (3m)12.82%
Revenue NQ rev (1m)2.16%
Revenue NQ rev (3m)3%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 59.94
Fwd PE 44.51
P/S 3.85
P/FCF 36.29
P/OCF 7.32
P/B 0.87
P/tB 0.98
EV/EBITDA 15.18
EPS(TTM)0.18
EY1.67%
EPS(NY)0.24
Fwd EY2.25%
FCF(TTM)0.3
FCFY2.76%
OCF(TTM)1.47
OCFY13.65%
SpS2.81
BVpS12.45
TBVpS11.06
PEG (NY)3.54
PEG (5Y)5.19
Profitability
Industry RankSector Rank
ROA 0.58%
ROE 1.37%
ROCE 2.49%
ROIC 1.97%
ROICexc 1.99%
ROICexgc 2.09%
OM 25.11%
PM (TTM) 6.06%
GM 66.01%
FCFM 10.6%
ROA(3y)0.92%
ROA(5y)0.71%
ROE(3y)2.06%
ROE(5y)1.57%
ROIC(3y)2.01%
ROIC(5y)1.84%
ROICexc(3y)2.02%
ROICexc(5y)1.84%
ROICexgc(3y)2.15%
ROICexgc(5y)1.97%
ROCE(3y)2.55%
ROCE(5y)2.33%
ROICexcg growth 3Y0.68%
ROICexcg growth 5Y5.74%
ROICexc growth 3Y1.21%
ROICexc growth 5Y6.75%
OM growth 3Y0.93%
OM growth 5Y3.54%
PM growth 3Y9.91%
PM growth 5Y17.22%
GM growth 3Y-2.38%
GM growth 5Y-1.67%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 46.93
Debt/EBITDA 8.7
Cap/Depr 130.68%
Cap/Sales 41.91%
Interest Coverage 1.41
Cash Conversion 91.83%
Profit Quality 174.99%
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 0.32
F-Score4
WACC6.46%
ROIC/WACC0.3
Cap/Depr(3y)37.42%
Cap/Depr(5y)50.13%
Cap/Sales(3y)12.22%
Cap/Sales(5y)18.43%
Profit Quality(3y)329.7%
Profit Quality(5y)551.61%
High Growth Momentum
Growth
EPS 1Y (TTM)-45.45%
EPS 3Y8.2%
EPS 5Y11.55%
EPS Q2Q%-16.67%
EPS Next Y16.95%
EPS Next 2Y12.95%
EPS Next 3Y27.51%
EPS Next 5YN/A
Revenue 1Y (TTM)2.89%
Revenue growth 3Y5.43%
Revenue growth 5Y12.33%
Sales Q2Q%3.84%
Revenue Next Year4.47%
Revenue Next 2Y6.67%
Revenue Next 3Y7.48%
Revenue Next 5Y6.98%
EBIT growth 1Y12.97%
EBIT growth 3Y6.41%
EBIT growth 5Y16.3%
EBIT Next Year176.67%
EBIT Next 3Y48.88%
EBIT Next 5YN/A
FCF growth 1Y-67.9%
FCF growth 3Y-6.64%
FCF growth 5YN/A
OCF growth 1Y21.99%
OCF growth 3Y-7.62%
OCF growth 5Y12.76%